Kawachi Pharmaceutical Co., Ltd. announced the implementation of an interim dividend beginning in the fiscal year ending March 2027, raising the annual dividend to 100 yen per share (an increase of 20 yen compared to the previous year).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2664","jir_company_name":"Kawachi Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/2664-20260428-03.pdf","jir_short_summary":"Kawachi Pharmaceutical Co., Ltd. announced the implementation of an interim dividend beginning in the fiscal year ending March 2027, raising the annual dividend to 100 yen per share (an increase of 20 yen compared to the previous year).","jir_summary":"### Overview of Implementation of Interim Dividend and Dividend Forecast\nKawachi Pharmaceutical Co., Ltd. has resolved to implement an interim dividend starting from the fiscal year ending March 2027 and to change the dividend from the current once-a-year year-end dividend to twice a year (interim and year-end). This aims to enhance opportunities for returning profits to shareholders. The record date for the interim dividend is set as September 15 each year. The dividend forecast for the fiscal year ending March 2027 anticipates a regular dividend of 100 yen per share, representing a 20 yen increase from the previous year. An interim dividend of 50 yen and a year-end dividend of 50 yen are planned.\n\n### Impact on Shareholders and Future Plans\nThe interim dividend will target shareholders listed or recorded in the shareholder registry as of September 15, 2026. The payment start date and dividend amount for the interim dividend will be formally resolved at the interim financial results board meeting. Additionally, the year-end dividend for the fiscal year ending March 2026 will be proposed at the 59th Annual General Meeting of Shareholders scheduled for June 2026. This change in the dividend system is expected to increase the timing of profit returns to shareholders and contribute to enhancing the stock value.","jir_financial_highlights":"Interim Dividend Record Date: September 15 each year (New Establishment)\nRegular Dividend for Fiscal Year Ending March 2027 (Annual Total): 100 yen 00 sen (20 yen increase compared to previous year)\nInterim Dividend Forecast for Fiscal Year Ending March 2027: 50 yen 00 sen (New Establishment)\nYear-end Dividend Forecast for Fiscal Year Ending March 2027: 50 yen 00 sen (Unknown)\nDividend Record for Fiscal Year Ending March 2026 (Total): 100 yen 00 sen (Regular dividend 80 yen 00 sen + commemorative dividend 20 yen 00 sen)","jir_category":"","jir_hashtags":"#KawachiPharmaceutical, #Dividend, #JapaneseStocks","jir_key_figures":"Interim Dividend Record Date: September 15 each year\nRegular Dividend Forecast for Fiscal Year Ending March 2027: 100 yen 00 sen (20 yen increase compared to previous year)\nInterim Dividend Forecast for Fiscal Year Ending March 2027: 50 yen 00 sen","jir_meta_title":"\u3010Kawachi Pharmaceutical\u3011 Dividend Increased to 100 Yen\uff5cInterim Dividend Starts from Fiscal Year Ending March 2027","jir_meta_description":"Kawachi Pharmaceutical Co., Ltd. will establish an interim dividend starting from the fiscal year ending March 2027 and plans to raise the annual dividend to 100 yen per share. As part of strengthening shareholder returns, dividends will be paid twice a year.","jir_og_title":"\u3010Kawachi Pharmaceutical\u3011 Dividend Increased to 100 Yen\uff5cInterim Dividend Starts from Fiscal Year Ending March 2027","jir_og_description":"Kawachi Pharmaceutical will begin interim dividends from the fiscal year ending March 2027 and plans to increase the annual dividend to 100 yen per share, enhancing shareholder returns.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16960,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-43681","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n